BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Singapore

Gilead and Kite Oncology Announce Cost-Effectiveness of Yescarta® in Large B-Cell Lymphoma in Singapore

Gilead and Kite Oncology announced new data from analyses of Yescarta® (axicabtagene ciloleucel), demonstrating its cost-effectiveness and budget impac...

June 14, 2024 | News

NSG BioLabs Partners with Eppendorf to Propel Biotech Startups in Singapore

Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the start...

June 13, 2024 | News

Gilead and Kite Oncology Announce Approval of Yescarta® for Early Treatment of DLBCL in Singapore

**-- In ZUMA-7, Yescarta Patients with DLBCL were 2.5 Times More Likely than SOC to be Alive at Two Years Without Cancer Progression or Nee...

June 10, 2024 | News

EnGeneIC and Singapore Institute of Advanced Medicine Partner to Transform Cancer Treatment in Asia

EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has announce...

June 07, 2024 | News

WuXi AppTec Breaks Ground on New R&D and Manufacturing Site in Singapore

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life scie...

May 24, 2024 | News

NUS Scientists Discover Novel Method to Activate Muscle Cells’ Natural Defences Against Cancer Using Magnetic Pulses

A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovation & Technology (iHealthtech) ...

May 22, 2024 | News

Experimental Drug Development Centre (EDDC) Announces Progression of Phase 1 Trial for EBC-129 into Dose Expansion

EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets cancer cells across ...

May 20, 2024 | News

AstraZeneca Announces $1.5 Billion Manufacturing Facility in Singapore for Cutting-Edge Cancer Treatments

AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global s...

May 20, 2024 | News

HSA Approves Arexvy, World's First RSV Vaccine, for Older Adults in Singapore

The Health Sciences Authority (HSA) of Singapore has approved Arexvy (recombinant, AS01E adjuvanted) for active immunisation to prevent lower respiratory t...

May 16, 2024 | News

AsiaMedic partners with Sunway to establish new diagnostic imaging centre

The planned close to 6,000 sqft facility at Royal Square in Novena is expected to commence operations by November 2024 and will nearly double AsiaMedic&r...

May 15, 2024 | News

A&D Invests $1M in Aevice Health to Expand Remote Respiratory Solutions

A&D Company, Limited has entered into a US$1M investment agreement with Aevice Health The collaboration is geared towards jointly expand...

May 15, 2024 | News

Allozymes Secures $15 Million Series A Funding to Transform Enzyme Engineering and Expand Global Presence

Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a $15 million Series A funding round led by Se...

May 15, 2024 | News

NSG BioLabs Secures $14.5 Million Investment, Expands Partnerships to Bolster Singapore's Biotech Ecosystem

NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investme...

May 08, 2024 | News

Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore

Cordlife also provided an update that as of 30 April 2024, a significant number of affected active clients whose cord blood units were stored in Ta...

May 08, 2024 | News

Stay Connected